IRIX

IRIDEX Corporation Common Stock (IRIX)

Stock · NASDAQ · Health Care

$0.71as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$1.03
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus

Fundamentals

Market cap
$14.36M
P/E (trailing)
P/E (forward)
EPS (trailing)
Dividend yield
Beta
Avg. volume

How IRIDEX Corporation Common Stock Makes Money

Where the revenue actually goes — FY2026 annual results

market-wall.comTotalRevenue$52.67MCost of Revenue$33.45M (63%)SG&A$18.13M (34%)R&D$3.67M (7%)Tax$57.0K (0%)IRIX

Source: 10-K filed Apr 2, 2026 · via SEC EDGAR / Finnhub

IRIDEX Corporation Common Stock Competitors

Chosen by industry and closest market cap.

  • IRIX
    IRIDEX Corporation Common Stock
    $0.71
    ▼ 0.42%
    Market cap $14.36MP/E
  • NXL
    Nexalin Technology Inc. Common Stock
    $0.25
    ▲ 0.00%
    Market cap $8.03MP/E
    $0.2201$2
  • NDRA
    ENDRA Life Sciences Inc. Common Stock
    $5.16
    ▼ 4.63%
    Market cap $5.19MP/E
    $2.96$9.85
  • VBIO
    Valion Bio Inc. Common Stock
    $0.121
    ▼ 1.63%
    Market cap $1.31MP/E
    $0.1116$1.3
  • QTI
    QT Imaging Holdings Inc. Common Stock
    $3.09
    ▼ 0.96%
    Market cap $36.21MP/E
    $2.62$19.05
  • POCI
    Precision Optics Corporation Inc. Common stock
    $4.41
    ▼ 0.45%
    Market cap $45.86MP/E
    $3.55$6.15
  • STEX
    Streamex Corp. Common Stock
    $0.7649
    ▼ 7.51%
    Market cap $78.10MP/E
    $0.6552$7.44

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
714.9K
Disposed
25.9K

Institutional Ownership

March 31, 2026

Total shares held
2.83M
Total value held
$2.86M
Institutional holders
23
Top holders this quarter
  • Unknown1.00M
  • Unknown514.6K
  • Unknown396.6K
  • Unknown259.6K
  • Unknown160.2K
  • Unknown60.9K
  • Unknown57.5K
  • Unknown55.3K
  • Unknown47.4K
  • Unknown44.7K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.